Achievement of Glycemic Targets when Switching from Basal-Bolus Therapy to V-Go for Insulin Delivery in Type 2 Diabetes

被引：0
|
作者：
Hundal, Ripu S.
Kowalyk, Stephan
Cases, Jane
Al-Karadsheh, Amer
Wakim, Amanda P.
Doyle, Melissa
Sink, John H., II
Spence, Adrienne
Brewer, Jamie L.
Nikkel, Carla C.
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-989-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clinical Evaluation of Basal-Bolus Therapy Delivered by the V-Go® Wearable Insulin Delivery Device in Patients with Type 2 Diabetes: A Retrospective Analysis
    Zeidan, Trisha
    Nikkel, Carla
    Dziengelewski, Beth
    Wu, Stephanie
    Chen, Aleda M. H.
    [J]. PHARMACY, 2020, 8 (04)
  • [2] Effectiveness of V-Go Wearable Insulin Delivery for Basal-Bolus Therapy-A Multicenter, Retrospective Real-World Evaluation in Type 2 Diabetes
    Hundal, Ripu S.
    Kowalyk, Stephan
    Cases, Jane
    Al-Karadsheh, Amer
    Wakim, Amanda P.
    Doyle, Melissa
    Sink, John H., II
    Spence, Adrienne
    Brewer, Jamie L.
    Nikkel, Carla C.
    [J]. DIABETES, 2018, 67
  • [3] Basal-bolus insulin therapy and glycemic control in adult patients with type 2 diabetes mellitus: A review of the literature
    Jackson, Bridget
    Grubbs, Laurie
    [J]. JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2014, 26 (06) : 348 - 352
  • [4] Switching from basal-bolus therapy with NPH insulin to basal-bolus therapy with the analog insulin detemir improves glycemic control and reduces hypoglycemic episodes, without weight gain, in type 1 and type 2 diabetes patients: Results from German subgroup of the PREDICTIVE study
    Ruhnau, Klaus-Juergen
    Hansen, Jes B.
    Dornhorst, Anne
    [J]. DIABETES, 2006, 55 : A133 - A133
  • [5] Switching From Insulin Bolus Treatment to GLP-1 RAs Added to Continued Basal Insulin in People With Type 2 Diabetes on Basal-Bolus Insulin
    Bolli, Geremia B.
    Porcellati, Francesca
    Meier, Juris J.
    [J]. DIABETES CARE, 2020, 43 (10) : 2333 - 2335
  • [6] Switching from a human insulin basal-bolus regimen to insulin analog basal-bolus therapy with insulin detemir/insulin aspart improves glycemic control and reduces hypoglycemic episodes in patients with type 1 diabetes:: Results from German subgroup of the PREDICTIVE™ study
    Maxeiner, Stephan
    Hansen, Jes B.
    Nauck, Michael
    [J]. DIABETES, 2006, 55 : A127 - A127
  • [7] Implementation of Basal-Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen
    Bergenstal, Richard M.
    Peyrot, Mark
    Dreon, Darlene M.
    Aroda, Vanita R.
    Bailey, Timothy S.
    Brazg, Ronald L.
    Frias, Juan P.
    Johnson, Mary L.
    Klonoff, David C.
    Kruger, Davida F.
    Ramtoola, Shenaz
    Rosenstock, Julio
    Serusclat, Pierre
    Weinstock, Ruth S.
    Naik, Ramachandra G.
    Shearer, David M.
    Zraick, Vivien
    Levy, Brian L.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (05) : 273 - 285
  • [8] Intensification of insulin therapy in patients with type 2 diabetes mellitus: An algorithm for basal-bolus therapy
    Abrahamson, Martin J.
    Peters, Anne
    [J]. ANNALS OF MEDICINE, 2012, 44 (08) : 836 - 846
  • [9] THE COSTS OF INTENSIFICATION FROM BASAL INSULIN TO BASAL-BOLUS IN TYPE 2 DIABETES: A SURVEY OF PHYSICIANS
    Pfeiffer, K. M.
    Basse, A.
    Brod, M.
    [J]. VALUE IN HEALTH, 2018, 21 : S74 - S74
  • [10] Improved Glycemic Control in Patients with Type 2 Diabetes Switching to the V-Go® Insulin Delivery Device: A Prospective Study Utilizing Continuous Glucose Monitoring
    Alzohaili, Opdada
    Whelan, Sheila
    Solaiman, Ahmad Yusuf
    Aldhalimy, Nadia
    Abbott, Scott
    Shi, Leon
    [J]. DIABETES, 2016, 65 : A259 - A259
12345